Estrogen sulfotransferase regulates body fat and glucose homeostasis in female mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 4, 2010, Pages

  Khor, Victor K ^a   Dhir, Ravindra ^a   Yin, Xiaoyan ^a   Ahima, Rexford S ^a   Song, Wen Chao ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adipogenesis; Adipose; Insulin; Leptin; Transgenic

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN SULFOTRANSFERASE; FATTY ACID SYNTHASE; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HORMONE SENSITIVE LIPASE; LEPTIN; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TESTOSTERONE; CHOLESTEROL ESTERASE; ESTROGEN; ESTRONE SULFOTRANSFERASE; SULFOTRANSFERASE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BROWN ADIPOSE TISSUE; CELL SIZE; FEMALE; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN SENSITIVITY; MACROPHAGE; MASS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RETROPERITONEAL FAT; SUBCUTANEOUS FAT; TRANSGENIC MOUSE; ANIMAL; BLOOD; BODY COMPOSITION; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; RANDOMIZATION; WHITE ADIPOCYTE;

ADIPOCYTES, WHITE; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; CELL DIFFERENTIATION; ESTROGENS; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; LEPTIN; LIPOPROTEIN LIPASE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PPAR GAMMA; RANDOM ALLOCATION; STEROL ESTERASE; SULFOTRANSFERASES; FATTY ACID SYNTHASES;

EID: 77957584982     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00707.2009     Document Type: Article

References (41)

1. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 99: 391-395, 1997.
2. Ahmed-Sorour H, Bailey CJ. Role of ovarian hormones in the long-term control of glucose homeostasis, glycogen formation and gluconeogenesis. Ann Nutr Metab 25: 208-212, 1981.
3. Akpan I, Goncalves MD, Dhir R, Yin X, Pistilli EE, Bogdanovich S, Khurana TS, Ucran J, Lachey J, Ahima RS. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) 33: 1265-1273, 2009.
4. Bjorntorp P. Adipose tissue distribution and function. Int J Obes 15, Suppl 2: 67-81, 1991.
5. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55: 978-987, 2006.
6. Diamanti-Kandarakis E, Christakou C, Kandarakis H. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Minerva Endocrinol 32: 35-47, 2007.
7. Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 286: C655-C661, 2004.
8. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295: 1288-1299, 2006.
9. Escobar-Morreale HF, San Millan JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 18: 266-272, 2007.
10. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82: 414-417, 1997.
11. Gaspard U. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 62: 362-365, 2009.
12. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6, Suppl 1: 60-75, 2009.
13. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97: 12729-12734, 2000.
14. Jones ME, Boon WC, McInnes K, Maffei L, Carani C, Simpson ER. Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 3: 414-421, 2007.
15. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97: 12735-12740, 2000.
16. Kaaja RJ. Metabolic syndrome and the menopause. Menopause Int 14: 21-25, 2008.
17. Khor VK, Tong MH, Qian Y, Song WC. Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse. Endocrinology 149: 5440-5448, 2008.
18. Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149: 91-97, 1993.
19. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR, MacDougald OA. Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem 279: 35503-35509, 2004.
20. Macotela Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58: 803-812, 2009.
21. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5: 197-216, 2004.
22. Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ, Kaplitt MG, Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 104: 2501-2506, 2007.
23. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085, 2003.
24. Price TM, O'Brien SN. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. J Clin Endocrinol Metab 77: 1041-1045, 1993.
25. Qian YM, Song WC. Regulation of estrogen sulfotransferase expression in Leydig cells by cyclic adenosine 3′,5′-monophosphate and androgen. Endocrinology 140: 1048-1053, 1999.
26. Qian YM, Sun XJ, Tong MH, Li XP, Richa J, Song WC. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 142: 5342-5350, 2001.
27. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4, Suppl B: S162-S177, 2007.
28. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 73: 874-879, 2008.
29. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8: 538-554, 2006.
30. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967, 2008.
31. Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav 97: 199-204, 2009.
32. Shi H, Seeley RJ, Clegg DJ. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol 30: 396-404, 2009.
33. Simpson ER, Ackerman GE, Smith ME, Mendelson CR. Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids. Proc Natl Acad Sci USA 78: 5690-5694, 1981.
34. Singhal NS, Patel RT, Qi Y, Lee YS, Ahima RS. Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295: E331-E338, 2008.
35. Song WC, Moore R, McLachlan JA, Negishi M. Molecular characterization of a testis-specific estrogen sulfotransferase and aberrant liver expression in obese and diabetogenic C57BL/KsJ-db/db mice. Endocrinology 136: 2477-2484, 1995.
36. Strott CA. Steroid sulfotransferases. Endocr Rev 17: 670-697, 1996.
37. Tong MH, Christenson LK, Song WC. Aberrant cholesterol transport and impaired steroidogenesis in Leydig cells lacking estrogen sulfotransferase. Endocrinology 145: 2487-2497, 2004.
38. Tong MH, Song WC. Estrogen sulfotransferase: discrete and androgen-dependent expression in the male reproductive tract and demonstration of an in vivo function in the mouse epididymis. Endocrinology 143: 3144-3151, 2002.
39. Varela GM, Antwi DA, Dhir R, Yin X, Singhal NS, Graham MJ, Crooke RM, Ahima RS. Inhibition of ADRP prevents diet-induced insulin resistance. Am J Physiol Gastrointest Liver Physiol 295: G621-G628, 2008.
40. Wade GN, Gray JM. Cytoplasmic 17 beta-[3H]estradiol binding in rat adipose tissues. Endocrinology 103: 1695-1701, 1978.
41. Wade GN, Gray JM, Bartness TJ. Gonadal influences on adiposity. Int J Obes 9, Suppl 1: 83-92, 1985.